Oracle Corporation
In the published model solve dated 2026-Q2, anchored at $150.95, Oracle Corporation (ORCL) is priced for +16.0% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed August 7, 2026 from SEC EDGAR filings.
• The contracted book Oracle has signed but not yet recognized as revenue reached 638 billion dollars at the May 2026 year end against 138 billion a year earlier, and management expects roughly 12% of it to convert to revenue over the following twelve months [Source: FY2026 Form 10-K, filed June 22, 2026]. • Serving that book is expensive: property and equipment purchases ran 55.7 billion dollars in fiscal 2026 against 32.0 billion of operating inflows, a shortfall of about 23.7 billion dollars
Is ORCL overvalued? See what's priced in →
3,391 institutional managers reported holding ORCL in 13F filings for the quarter ended 2026-03-31. Together they hold about 40% of the company; the top 10 hold 20%. 140 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 37.7M shares were sold short as of the 2026-06-15 count, about 1% of shares outstanding (1.2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ORCL's share count grew 3.8% over the past five years even with $19.45B spent on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting), raised 16 years straight; the current rate is $2.00 a share annually. Cash returned over the past three years: $14.92B in dividends and $1.90B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at ORCL over the trailing three years: 2025: 2 buys totaling $1.06M. 21 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ORCL's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-06-21 | +6.2% | -3.5% |
| 2023-09-13 | -13.2% | +2.0% |
| 2023-12-13 | -11.3% | +10.9% |
| 2024-03-13 | +13.4% | -3.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ORCL's latest 8-K filings: 2026-06-10 (items 2.02, 8.01, 9.01); 2026-05-12 (items 5.02, 7.01, 9.01); 2026-04-06 (items 5.02, 7.01, 9.01); 2026-03-10 (items 2.02, 8.01, 9.01); 2026-02-05 (items 1.01, 3.03, 5.03, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: August 7, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.